Good MorningEquity markets rallied on Friday to end the week higher after rates on the 10-year treasury pulled back from the critical 4.0% level. The move should not be trusted due to the ongoing impacts of inflation and the outlook for FOMC interest rate hikes. The latest data shows inflation is accelerating and the Fed is on track to hike rates well above the 5.0% level. The risk for the market is that next week's NFP data will be vital and coupled with rising wages that will keep the Fed on its current path.
Next week brings another round of earnings reports although the peak of Q4 reporting is long past. Next week's reports include many small and mid-cap names along with Oracle. Oracle is noteworthy because it marks the mid-point between peak earnings season and the start of Q1 reporting. The company is expected to report a significant increase in YOY revenue and earnings that may be hard to match. Featured: Sell these "safe" blue chips immediately (Ad) 
|
Technology | |
Newly public companies are often among the market’s biggest percentage gainers, and 2021 initial public offerings Globalfoundries Inc. (NASDAQ: GFS), On Holding AG (NYSE: ONON), and Qualtrics International Inc. (NASDAQ: XM) may be setting up for a fresh round of price gains.
Fortunately fo... Read the Full Story |
|
From Our Partners | | Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief.
It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. | | Watch the full story and see the verified track record for yourself |
|
Energy | |
The stock market has changed over the last year, and it no longer favors unprofitable fad stocks. These days, companies with yield, quality assets, and resilient business models are reaping the rewards. It's a shift that value investors say comes about a decade late.
After all, why bother with st... Read the Full Story |
|
Finance | |
Canadian financial institutions Royal Bank of Canada (NYSE: RY), Bank of Montreal (NYSE: BMO), and Bank of Novia Scotia (NYSE: BNS) all raised their dividends since February 28, as MarketBeat’s data on recent dividend increases show.
All three banks are large caps and heavily weighted comp... Read the Full Story |
|
From Our Partners | | Moderna's stock doubled in a single day after its cancer vaccine hit key Phase 3 goals, and Merck jumped too. But according to a former Steve Cohen fund manager, the next big opportunity is not Moderna or Merck.
It is a different kind of company tied to a technology already backed by Elon Musk, Sam Altman, Jeff Bezos, and Peter Thiel. Nvidia's Jensen Huang says it will have a dramatic impact on daily life, while Anthropic's CEO believes it could unlock a century of medical progress in just ten years.
Nature Magazine estimates its potential value at $367 trillion globally, and it is already rolling out across the United States. | | Click here to learn about this new era of medical technology |
|
Technology | |
February was a tough month for the market but all is not lost. Stocks like Salesforce.com (NYSE: CRM), Meta Platforms (NASDAQ: META), and NVIDIA (NASDAQ: NVDA) came out with many upgrades that have these stocks not only bottoming but in reversal. While hurdles remain, these market-leading best-in-... Read the Full Story |
|
Technology | |
Is Zscaler (NASDAQ: ZS) buyable on this dip? Wedbush analyst Dan Ives thinks so. In his view, the Q4 billings were not a wow number, which is one reason the market is moving lower. Based on the outlook for federal spending and the long-term outlook for cyber-security spending, the pullback is an o... Read the Full Story |
|
From Our Partners | | Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required.
Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. | | Discover the gold income fund before the next payout date |
|
Markets | |
The semiconductor industry had been peaceful for several years before the COVID-19 pandemic. The biggest and most powerful players shared a level playing field regarding supply chains, market share, and intellectual property barriers. That was the case until the presidential term of 2016-2020, whi... Read the Full Story |
|
Markets | |
If you own a portfolio of dividend stocks, you might wonder how to earn more income from your investments.
You can follow one simple strategy to unlock more income from your portfolio. This strategy involves limited risk and may also lead to appreciable upside returns.
Let’s cover this st... Read the Full Story |
|
Consumer Discretionary | |
It’s too soon to call October 13th the low for U.S. stocks. With the Federal Reserve steadfast in its view of higher rates for longer, equity valuations may not have yet reached the basement.
The good news is that the stock market has distanced itself from its 2022 bottom. And with some Fed... Read the Full Story |
|
Energy | |
Oil tankers have been on an uptrend for the past year, with no real signs of slowing down. In one of the latest developments, Nordic American Tanker Ltd. (NYSE: NAT) on February 27, boosted its shareholder payout by 200%, from $0.05 a share to $0.15, according to MarketBeat data on dividend increa... Read the Full Story |
|
Technology | |
High-growth cloud computing firm Snowflake (NYSE: SNOW) reported earnings after the close on Wednesday, and the results were not what investors were hoping for. The stock dropped by 11% following the earnings report, which showed disappointing guidance.
Snowflake is one of the fastest-growing tec... Read the Full Story |
|
Monday's Early Bird Stock Of The Day Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. | | View Today's Stock Pick |
|
